We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00531687
Recruitment Status : Terminated (slow accrual)
First Posted : September 19, 2007
Last Update Posted : October 3, 2017
Information provided by (Responsible Party):

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : February 2012
  Study Completion Date : October 2016